Tandem Diabetes Care acquires infusion set developer Capillary Biomedical

Tandem Diabetes Care, Inc. announced its acquisition of Capillary Biomedical, an infusion set developer. Financial terms were not disclosed.

“Through this acquisition, and through our efforts with existing infusion set partners, we look forward to developing new and innovative infusion set solutions that are designed to extend wear time and enhance user experience, while reducing occlusions, body burden and waste.”investor.tandemdiabetes.com

• 1 source
• investor.tandemdiabetes.comTandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical | Tandem Diabetes CareJul 21, 2022

Summarized from public sources; check the original articles before acting on it.